ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) Stock Price, Forecast & Analysis
Europe - Euronext Oslo - OSL:AZT - NO0010014632 - Common Stock
AZT.OL Key Statistics, Chart & Performance
The current stock price of AZT.OL is 19.1 NOK. In the past month the price decreased by -22.67%. In the past year, price increased by 39.62%.
AZT.OL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ARGX.BR | ARGENX SE | 72.12 | 47.42B | ||
| 1AE.DE | ARGENX SE | 71.89 | 47.27B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 19.60B | ||
| ABVX.PA | ABIVAX SA | N/A | 8.86B | ||
| 2X1.DE | ABIVAX SA | N/A | 8.16B | ||
| GLPG.AS | GALAPAGOS NV | N/A | 1.82B | ||
| GXE.DE | GALAPAGOS NV | N/A | 1.80B | ||
| 5CV.DE | CUREVAC NV | 7.62 | 994.80M | ||
| NANO.PA | NANOBIOTIX | N/A | 926.70M | ||
| IVA.PA | INVENTIVA SA | N/A | 724.91M | ||
| 6IV.DE | INVENTIVA SA | N/A | 678.11M | ||
| PHIL.MI | PHILOGEN SPA | 20.09 | 669.60M |
Related stock screener links
About AZT.OL
Company Profile
ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms and currently employs 55 full-time employees. The company went IPO on 2005-11-04. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Company Info
ARCTICZYMES TECHNOLOGIES ASA
Sykehusveien 23
Tromso TROMS NO
Employees: 53
Phone: 4777648900
ARCTICZYMES TECHNOLOGIES ASA / AZT.OL FAQ
What does ARCTICZYMES TECHNOLOGIES ASA do?
ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms and currently employs 55 full-time employees. The company went IPO on 2005-11-04. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Can you provide the latest stock price for ARCTICZYMES TECHNOLOGIES ASA?
The current stock price of AZT.OL is 19.1 NOK.
Does AZT stock pay dividends?
AZT.OL does not pay a dividend.
What is the ChartMill technical and fundamental rating of AZT stock?
AZT.OL has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Would investing in ARCTICZYMES TECHNOLOGIES ASA be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AZT.OL.
How many employees does ARCTICZYMES TECHNOLOGIES ASA have?
ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) currently has 53 employees.
AZT.OL Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to AZT.OL. When comparing the yearly performance of all stocks, AZT.OL turns out to be only a medium performer in the overall market: it outperformed 51.06% of all stocks.
AZT.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AZT.OL. AZT.OL has an excellent financial health rating, but there are some minor concerns on its profitability.
AZT.OL Financial Highlights
Over the last trailing twelve months AZT.OL reported a non-GAAP Earnings per Share(EPS) of 0.12.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.86% | ||
| ROA | 0.8% | ||
| ROE | 0.86% | ||
| Debt/Equity | 0.01 |
AZT.OL Forecast & Estimates
6 analysts have analysed AZT.OL and the average price target is 33.66 NOK. This implies a price increase of 76.23% is expected in the next year compared to the current price of 19.1.
For the next year, analysts expect an EPS growth of -2.61% and a revenue growth 4.69% for AZT.OL